The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease

Neuroscience

Volumn 85, Issue 4, 1998, Pages 1337-1340

  Arendt, T ^a   Holzer, M ^a   Bruckner, M K ^a   Janke, C ^a   Gartner, U ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OKADAIC ACID;

ALZHEIMER DISEASE; ANIMAL CELL; DOSE RESPONSE; EPITOPE MAPPING; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; STRUCTURE ANALYSIS;

EID: 0031798653     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00697-0     Document Type: Note

References (31)

1. Arendt Th. Neuronal dedifferentiation and degeneration in Alzheimer's disease Biol. Chem. Hoppe-Sevler 374 1993 911 912
2. Arendt Th. Hanisch F. Holzer M. Brückner M.K. In vivo phosphorylation in the rat basal nucleus induces PHF-like and APP immunoreactivity NeuroReport 5 1994 1397 1400
3. Arendt Th. Holzer M. Fruth R. Brückner M.K. Gärtner U. Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A Neuroscience 69 1995 691 698
4. Arendt Th. Holzer M. Fruth R. Brückner M.K. Gärtner U. Formation of highly phosphorylated tau and Aβ-amyloid in rat brain after inhibition of phosphatases 1 and 2A. Time course of evolvement and relationship to apoptotic cell death Neurobiol. Aging 1998 (in press)
5. Arendt Th. Holzer M. Fruth R. Brückner M.K. Janke C. Gärtner U. Chronic inhibition of phosphatases 1 and 2A in rat brain: a non-transgenic model of Alzheimer's disease Iqbal K. Winblad B. Nishimura T. Takeda M. Wisniewski H.M. Alzheimer's Disease: Biology, Diagnosis and Therapeutics 1997 John Wiley and Sons Ltd. New York 585 592
6. Arendt Th. Holzer M. Gärtner U. Brückner M.K. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease J. neural Transm. 1998 (in press)
7. Arendt Th. Rödel L. Gärtner U. Holzer M. Expression of the cyclin-dependent kinase inhibitor pl6 in Alzheimer's disease NeuroReport 7 1996 3047 3049
8. Cummings B.J. Hayward N. Stolzner S. Molineaux S. Nixon R.A. Intraventricular infusion of okadaic acid induces mild changes in tau and APP, but fails to produce AD-like neuropathology in adult rats Soc. Neurosci. Abstr. 232 1997 1639
9. Drewes G. Mandelkow E.M. Baumann K. Goris J. Merlevede W. Mandelkow E. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase 2A Fedn Eur. biochem. Socs Lett. 336 1993 425 432
10. Gärtner U. Janke C. Holzer M. Vanmechelen E. Arendt Th. Postmortem changes in the phosphorylation state of tau protein in rat brain Neurobiol. Aging 1998 (in press)
11. Goedert M. Cohen E.S. Jakes R. Cohen P. p42 MAP kinase phosphorylation sites in microtubuleassociated protein tau are dephosphorylated by protein phosphatase 2A1—implication for Alzheimer's disease Fedn Eur. biochem. Socs Lett. 312 1992 95 99
12. Goedert M. Spillantini M.G. Cairns N.J. Crowther R.A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six isoforms Neuron 8 1992 159 168
13. Gong C.X. Singh T.J. Grundke-Iqbal I. Iqbal K. Phosphoprotein phosphatase activities in Alzheimer's disease brain J. Neurochem. 61 1993 921 927
14. Gong C.X. Wegiel J. Wisniewski H.M. Badmajew E. Tanaka T. Grundke-Iqbal I. Iqbal K. Tau pathology in brain of rats after chronic treatment with okadaic acid Neurobiol. Aging 17 Suppl. 1996 S133
15. Heintz N. Cell death and the cell cycle-a relationship between transformation and neurodegeneration Trends biochem. Sci. 18 1993 157 159
16. Janke C. Gärtner U. Fruth R. Holzer M. Arendt Th. Reversible hyperphosphorylation of Tau induced by intracerebral injection of the phosphatase inhibitor okadaic acid and by unspecific brain lesion in rat J. Neurosci. Res. 1998 (in press)
17. LC Laboratories: New Product Bulletin December 1990
18. New Product Bulletin November 1991
19. The Messenger Vol. 1 No. 2 August 1992
20. The Messenger Vol. 3 No. 1 July 1994
21. Lee V.M.-Y. Balin B.J. Otvos L. Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal soluble tau Science 251 1991 675 678
22. Matsuo E.S. Shin R.W. Billingsley M.L. Vandevoorde A. O'Connor M. Trojanowski J.Q. Lee V.M.Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau Neuron 13 1994 989 1002
23. Mudher A.K. Perry V.H. Using okadaic acid as a tool for the in vivo induction of hyperphosphorylated tau Neuroscience 85 1998 1329 1332
24. Nagy Z. Esiri M.M. Cato A.-M. Smith A.D. Cell cycle markers in the hippocampus in Alzheimer's disease Acta neuropath. 94 1997 6 15
25. Nagy Z. Esiri M.M. Smith A.D. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions Acta neuropath. 93 1997 294 300
26. Nelson P.T. Saper C.B. Injections of okadaic acid, but not beta-amyloid peptide, induce Alz-50 immunoreactive dystrophic neurites in the cerebral cortex of sheep Neurosci. Lett. 208 1996 77 80
27. Sun X. Frautschy S.A. Chu T. Teter B. Yang F. Schubert D. Cole G.M. Activation of apoptosis by okadaic acid modulates AB production and the processing of amyloid precursor protein in a transfected neuronal cell line Soc. Neurosci. Abstr. 231 1997 842
28. Van Dam A.-M. Bol J.G.J.M. Binnekade R. van Muiswinkel F.L. Acute or chronic administration of okadaic acid to rats induces brain damage rather than Alzheimer-like neuropathology Neuroscience 85 1998 1333 1335
29. Vincent I. Jicha G. Rosado M. Dickson D.W. Aberrant expression of mitogenic Cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain J. Neurosci. 17 1997 3588 3598
30. Vincent I. Rosado M. Davies P. Mitogenic mechanisms in Alzheimer's disease? J. Cell Biol. 132 1996 413 425
31. Wilton K. Manser K. Good M. Chronic i.c.v. infusion of okadaic acid produces differential effects on spatial working and reference memory in rats Soc. Neurosci. Abstr. 232 1997 2170